Dividend investors rarely argue with a healthy payout increase — as long as the company can afford that increase. Nobody wants to face the potential of a painful cut further down the line.
Recently, this medical device company authorized an increase in its quarterly dividend from $0.58 per share to $0.63. An 8.6% increase to a forward yield of 2% is nothing to sneeze at, especially when compared with the S&P 500’s 1.3% average yield. It may signal that the company is doing fundamentally well and management is looking to return more capital to shareholders to drive returns.
The new dividend obligation could be an unsupportable amount, significantly if the fundamentals are weakening. Here’s a look at whether this medical device company remains a safe stock to invest in.